Diabetes decisions — 2024

The Veteran's diabetes mellitus type II is granted as service-connected due to exposure to Agent Orange during his active duty.

The Veteran's claim for compensation under 38 U.S.C. § 1151 for an infection, status post total right knee replacement is denied because he did not have a current disability characterized as an infection of the right knee during the claim period.

The Veteran withdrew their appeal regarding the increased disability evaluation for service-connected diabetes mellitus type II with associated herbicide exposure.

The Veteran's bilateral hearing loss is granted as service-connected, but his diabetes mellitus remains denied due to lack of qualifying military exposure.

The Veteran's neurocognitive disorder is granted as secondary to his service-connected PTSD. The Veteran also qualifies for SMC based on the need for aid and attendance due to multiple service-connected disabilities.

The Veteran's bilateral hearing loss was rated as noncompensable, and the appeal for an increased rating is denied.,There is no current diagnosis of hepatitis C during the appeal period, and service connection for this condition is not granted.

The Veteran withdrew his appeal regarding diabetes mellitus, type II.

The Veteran's service-connected Diabetes Mellitus Type II and bilateral lower extremity diabetic peripheral neuropathy have been granted effective from the dates of their respective diagnoses.,An earlier effective date for the Veteran's service connection is granted, with specific effective dates provided for each condition.

The Board has denied service connection for diabetes mellitus type II and remanded the issues of service connection for anxiety disorder, assignment of a compensable rating for bilateral hearing loss, and TDIU due to unresolved VA duties to assist.

The Board has granted service connection for hypertension and diabetes due to herbicide exposure. The claim of service connection for chronic renal disease is remanded as the Veteran's exposure basis was not addressed.

The Veteran's service-connected diabetic peripheral neuropathy of the bilateral lower extremities was rated based on inadequate information without a VA examination, which is considered a duty to assist error. The Board has therefore remanded these claims for further evaluation.

The Veteran's claims for earlier effective dates for service connection of diabetes mellitus type II and right knee strain were denied as there was no new and material evidence received within the applicable appeal period.

The Veteran's claims for prostate cancer, lung cancer, ischemic heart disease, and type II diabetes mellitus are remanded due to inadequate VA examination.

The Veteran's migraine headaches are rated at 30 percent prior to May 6, 2022 and 50 percent beginning on that date. The Veteran is granted service connection for major depressive disorder and secondary service connection for obstructive sleep apnea.,Service connection for coronary artery disease and diabetes mellitus type II remains pending as the claims are remanded.

The Board has remanded the case due to an inadequate VA examination, and a new medical opinion is needed regarding whether the Veteran's celiac disease is proximately due or aggravated by his service-connected diabetes mellitus.

The Board has remanded the claims for service connection for peripheral neuropathy as secondary to diabetes mellitus type II and TDIU due to conflicting medical evidence regarding the presence of a current diagnosis of peripheral neuropathy.

The Board has dismissed the appeal of the issue regarding service connection for diabetes mellitus type II (DM) as it is still pending at the RO level.

The appeals regarding chronic kidney disease and ischemic heart disease have been dismissed as the AOJ has already granted service connection for these conditions in previous decisions.

The Veteran's claim for an earlier effective date for the assigned 20 percent ratings for his service-connected diabetic peripheral neuropathy, right and left lower extremity anterior crural nerves is denied.

The Board has remanded the claims for hypertension, ischemic heart disease, prostate cancer, and type II diabetes mellitus due to herbicide agent exposure as there are errors in pre-decisional duty-to-assist actions.